Results 11 to 20 of about 6,936,275 (302)
MHC II–EGFP Knock‐in Mouse Model [PDF]
AbstractThe MHC II–EGFP knock‐in mouse model enables us to visualize and track MHC‐II‐expressing cells in vivo by expressing enhanced green fluorescent protein (EGFP) fused to the MHC class II molecule under the MHC II beta chain promoter. Using this model, we can easily identify MHC‐II‐expressing cells, including dendritic cells, B cells, macrophages,
Jan Pačes +7 more
openaire +4 more sources
Conditional Ablation of MHC-II Suggests an Indirect Role for MHC-II in Regulatory CD4 T Cell Maintenance [PDF]
Abstract Although the importance of MHC class II (MHC-II) in acute homeostatic proliferation of regulatory T (Treg) cells has been established, we considered here the maintenance and state of Treg cells in mice that are almost completely devoid of MHC-II in their periphery but still make their own CD4 T cells and Treg cells.
Michiko, Shimoda +7 more
openaire +3 more sources
Regulation of MHC Class II-Peptide Complex Expression by Ubiquitination
MHC class II (MHC-II) molecules are present on antigen presenting cells (APCs) and these molecules function by binding antigenic peptides and presenting these peptides to antigen-specific CD4+ T cells.
Kyung Jin eCho, Paul A. Roche
doaj +2 more sources
Human Intestinal Enteroids Model MHC-II in the Gut Epithelium [PDF]
The role of intestinal epithelial cells (IECs) in mucosal tolerance and immunity remains poorly understood. We present a method for inducing MHC class II (MHC-II) in human enteroids, “mini-guts” derived from small intestinal crypt stem cells, and show ...
Jonathan E. Wosen +9 more
doaj +3 more sources
Essential role of MHC II in the antitubercular efficacy of pyrazinamide. [PDF]
Abstract Antibacterial drug mechanisms have traditionally been examined through a drug-pathogen lens, often overlooking the host’s role in shaping drug activity. However, growing evidence suggests that the host environment is crucial for antibacterial efficacy.
Lamont EA +7 more
europepmc +4 more sources
The melting pot of the MHC II peptidome [PDF]
Recent advances in mass spectrometry technology have facilitated detailed examination of MHC-II immunopeptidomes, for example the repertoires of peptides bound to MHC-II molecules expressed in antigen presenting cells. These studies have deepened our view of MHC-II presentation.
Lawrence J, Stern, Laura, Santambrogio
openaire +2 more sources
TRIM22 negatively regulates MHC-II expression
The development of cancer treatment has recently achieved a remarkable breakthrough, and checkpoint blockade immunotherapy has received much attention. To enhance the therapeutic efficacy of checkpoint blockade immunotherapy, recent studies have revealed the importance of activation of CD4+ T cells via an increase in major histocompatibility complex ...
Inoue, Ayano +4 more
openaire +3 more sources
MHC-II binding prediction results of VirB8 (IEDB).
MHC-II binding prediction results of VirB8 (IEDB).
Ce Niu (16814125) +10 more
core +1 more source
A large proportion of anti-tumor immunity research is focused on major histocompatibility complex class I (MHC-I) molecules and CD8+ T cells. Despite mounting evidence has shown that CD4+ T cells play a major role in anti-tumor immunity, the role of the ...
Ruibin Yi +11 more
doaj +1 more source
MHC-II binding prediction results of VirB10 (IEDB).
MHC-II binding prediction results of VirB10 (IEDB).
Ce Niu (16814125) +10 more
core +1 more source

